Given that G6PD is one of the primary regulatory factors of ccRCC metabolic disorders and can be manipulated by BANCR, it is currently unclear to what extent BANCR is involved in the metabolic reprogramming of ccRCC or other cancers. Here, G6PD is linked to nonpapillary renal cell carcinoma.